0001209191-23-012672.txt : 20230224 0001209191-23-012672.hdr.sgml : 20230224 20230224160638 ACCESSION NUMBER: 0001209191-23-012672 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230222 FILED AS OF DATE: 20230224 DATE AS OF CHANGE: 20230224 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Arbuckle Stuart A CENTRAL INDEX KEY: 0001557290 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 23667047 MAIL ADDRESS: STREET 1: VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-02-22 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001557290 Arbuckle Stuart A C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP, COO Common Stock 2023-02-22 4 S 0 129 291.84 D 68576 D Common Stock 2023-02-22 4 S 0 300 292.86 D 68276 D Common Stock 2023-02-22 4 S 0 1378 294.29 D 66898 D Common Stock 2023-02-22 4 S 0 394 295.38 D 66504 D Common Stock 2023-02-22 4 S 0 200 296.31 D 66304 D Common Stock 140 I 401(k) Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $291.84 (range $291.17 to $292.03). Open market sales reported on this line occurred at a weighted average price of $292.86 (range $292.44 to $293.37). Open market sales reported on this line occurred at a weighted average price of $294.29 (range $293.83 to $294.82). Open market sales reported on this line occurred at a weighted average price of $295.38 (range $294.83 to $295.72). Open market sales reported on this line occurred at a weighted average price of $296.31 (range $296.20 to $296.41). /s/ Christiana Stevenson, Attorney-in-Fact 2023-02-24